SCHEMBL25812007

SCHEMBL25812007

Cc1ccc(Sc2ccc(Cl)cc2-c2ccccc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE7A Q13946 1/20 0.43
PDE7B Q9NP56 1/20 0.43
L3MBTL1 Q9Y468 3/20 0.40
NPSR1 Q6W5P4 2/20 0.40
ALDH1A1 P00352 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 1/20 0.40
ATM Q13315 1/20 0.40
HTR1A P08908 1/20 0.40
HTR3A P46098 1/20 0.40
MAPT P10636 4/20 0.39
TP53 P04637 1/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
TDP1 Q9NUW8 2/20 0.39
HKDC1 Q2TB90 1/20 0.39
KDM4E B2RXH2 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24871308 0.90 ALDH1A1 (0.47) PDE7APDE7BL3MBTL1NPSR1ALDH1A1
SCHEMBL25811691 0.87 MAPT (0.43) L3MBTL1NPSR1ALDH1A1SMN1; SMN2LMNA
SCHEMBL27430977 0.84 HPRT1 (0.46) L3MBTL1NPSR1ALDH1A1SMN1; SMN2LMNA
SCHEMBL13750090 0.82 HTR1A (0.47) L3MBTL1NPSR1ALDH1A1SMN1; SMN2LMNA
SCHEMBL14712749 0.80 L3MBTL1 (0.50) L3MBTL1NPSR1SMN1; SMN2LMNAHTR1A
SCHEMBL24972708 0.76 MAPT (0.49) L3MBTL1ALDH1A1SMN1; SMN2LMNAMAPT
SCHEMBL29242030 0.76 SLC6A4 (0.47) L3MBTL1NPSR1ALDH1A1SMN1; SMN2LMNA
SCHEMBL576376 0.76 HDAC7 (0.46) L3MBTL1NPSR1ALDH1A1LMNAHTR1A
SCHEMBL28588713 0.73 HPGD (0.46) PDE7APDE7BL3MBTL1NPSR1ALDH1A1
SCHEMBL17968242 0.73 MAOA (0.43) ALDH1A1LMNAMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4234524-A2 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF Duk San Neolux Co., Ltd. (KR) 2023-08-30 EP disclosed
EP-4219436-A2 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF Duk San Neolux Co., Ltd. (KR) 2023-08-02 EP disclosed
US-20230189636-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230189636-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF EMC1, EMC2, EPCAM PDE7A 4441/4885PDE7B 4315/4885L3MBTL1 4141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.